Doptelet (avatrombopag) / SOBI  >>  Phase 4
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Doptelet (avatrombopag) / SOBI
AIPAC, NCT04845659: Avatrombopaq In Patients With Cirrhosis

Not yet recruiting
4
20
NA
Doptelet Pill
Hvidovre University Hospital
Thrombocytopenia; Drugs, Cirrhosis, Liver, Procedural Bleeding
06/22
06/22
ChiCTR2100050045: A Study to Assess the Safety and Efficacy of Avatrombopag in Chinese Patients with Aplastic Anemia

Not yet recruiting
4
60
 
Avatrombopag treatment
Tianjin Medical University, General Hospitial; Tianjin Medical University General Hospitial, self-raised
aplastic anemia
 
 
EAST, NCT04906083: Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

Recruiting
4
150
RoW
Avatrombopag, Standard medical treatment, transmetil, compound glycyrrhizinate, reduced glutathione and hepatocyte growth factor, et. al.
Tongji Hospital, Anhui Provincial Hospital, The First Affiliated Hospital of Nanchang University, Taihe Hospital, Hubei University of Medicine, The First Hospital of Jilin University
Liver Failure, Thrombocytopenia, Decompensated Cirrhosis
12/22
12/22
NCT04915287: Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

Recruiting
4
476
RoW
Avatrombopag maleate, Doptelet, Platelet transfusion, Medicine, Other drugs
Chinese PLA General Hospital
Thrombocytopenia; Drugs, Chronic Liver Disease
06/23
07/23
ChiCTR2200065912: Efficacy and safety of avatrombopag in immune/targeted/antiangiogenic hepatocellular carcinoma patients with thrombocytopenia

Recruiting
4
76
 
Avatrombopag was administered orally
Fuyang Second People's Hospital; Fuyang Second People's Hospital, Self-funded
Hepatoma
 
 
NCT04638829: Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Completed
4
60
US
Avatrombopag Oral Tablet, Doptelet
Sobi, Inc.
Immune Thrombocytopenia
01/24
01/24
NCT05382013: Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment

Recruiting
4
60
RoW
Avatrombopag, Artificial Liver Support System, Comprehensive internal medical treatment.
Third Affiliated Hospital, Sun Yat-Sen University
Thrombocytopenia, Hepatitis B, Chronic, Acute-On-Chronic Liver Failure
02/24
04/24
ChiCTR2200057674: Clinical study of Avatrombopag combined with immunosuppressive therapy in the treatment of severe hepatitis-related aplastic anemia in children

Not yet recruiting
4
10
 
Avatrombopag
Capital Medical University, National Center for Children’s Health; Capital Medical University, National Center for Children’s Health, Self-financing
Severe hepatitis-associated aplastic anaemia in children
 
 
NCT05996393: CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly

Not yet recruiting
4
60
RoW
Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit
Peking Union Medical College Hospital
Aplastic Anemia
10/25
10/26

Download Options